CYFRA 21-1, CA 125 and CEA provide additional prognostic value in NSCLC patients with stable disease at first CT scan
出版年份 2023 全文链接
标题
CYFRA 21-1, CA 125 and CEA provide additional prognostic value in NSCLC patients with stable disease at first CT scan
作者
关键词
-
出版物
TUMOR BIOLOGY
Volume -, Issue -, Pages 1-13
出版商
IOS Press
发表日期
2023-10-14
DOI
10.3233/tub-220042
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Serum tumor markers for response prediction and monitoring of advanced lung cancer: A review focusing on immunotherapy and targeted therapies
- (2023) Michel van den Heuvel et al. TUMOR BIOLOGY
- Considerations for the Utility of Real-World Evidence Beyond Trial Data in Advanced NSCLC: The Case of Frontline Tyrosine Kinase Inhibitors
- (2022) Priyanka Gaitonde et al. Cancer Management and Research
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Biomarkers of Checkpoint Inhibitor Induced Immune-Related Adverse Events—A Comprehensive Review
- (2021) Josefien W. Hommes et al. Frontiers in Oncology
- P22.02 Combined Use of CYFRA 21-1, CA125 and CRP Predicts Survival of Metastatic NSCLC Patients With Stable Disease
- (2021) A. Mang et al. Journal of Thoracic Oncology
- Pseudoprogression and Hyperprogression as New Forms of Response to Immunotherapy
- (2020) Maxime Frelaut et al. BIODRUGS
- Patient and carer perceived barriers to early presentation and diagnosis of lung cancer: a systematic review
- (2019) Shemana Cassim et al. BMC CANCER
- Monitoring anti-PD-1-based immunotherapy in non-small cell lung cancer with FDG PET: introduction of iPERCIST
- (2019) Lucas Goldfarb et al. EJNMMI Research
- Circulating free tumor DNA in non-small cell lung cancer (NSCLC): clinical application and future perspectives
- (2019) Guillaume Herbreteau et al. Journal of Thoracic Disease
- Carcinoembryonic antigen and CYFRA 21-1 responses as prognostic factors in advanced non-small cell lung cancer
- (2019) Akihiro Yoshimura et al. Translational Lung Cancer Research
- Treatment patterns and overall survival in metastatic non-small-cell lung cancer in a real-world, US setting
- (2019) Jason C Simeone et al. Future Oncology
- Patterns of responses in metastatic NSCLC during PD-1 or PDL-1 inhibitor therapy: Comparison of RECIST 1.1, irRECIST and iRECIST criteria
- (2018) M. Tazdait et al. EUROPEAN JOURNAL OF CANCER
- The combination of the blood based tumor biomarkers cytokeratin 19 fragments (CYFRA 21-1) and carcinoembryonic antigen (CEA) as a potential predictor of benefit from adjuvant chemotherapy in early stage squamous cell carcinoma of the lung (SCC)
- (2018) Thomas Muley et al. LUNG CANCER
- OUP accepted manuscript
- (2018) ANNALS OF ONCOLOGY
- Current landscape and future directions of biomarkers for predicting responses to immune checkpoint inhibitors
- (2018) Yingming Zhu et al. Cancer Management and Research
- Evaluating tumor response with FDG PET: updates on PERCIST, comparison with EORTC criteria and clues to future developments
- (2017) Katja Pinker et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Progress and prospects of early detection in lung cancer
- (2017) Sean Blandin Knight et al. Open Biology
- The Combination of the Tumor Markers Suggests the Histological Diagnosis of Lung Cancer
- (2017) Linjie Liu et al. Biomed Research International
- The relationship between glasgow prognostic score and serum tumor markers in patients with advanced non-small cell lung cancer
- (2015) Ai-Gui Jiang et al. BMC CANCER
- Inter-observer reproducibility of semi-automatic tumor diameter measurement and volumetric analysis in patients with lung cancer
- (2013) J. Dinkel et al. LUNG CANCER
- Intra- and Interobserver Variability in CT Measurements in Oncology
- (2013) Aoife McErlean et al. RADIOLOGY
- Variability of Lung Tumor Measurements on Repeat Computed Tomography Scans Taken Within 15 Minutes
- (2011) Geoffrey R. Oxnard et al. JOURNAL OF CLINICAL ONCOLOGY
- New CT response criteria in non-small cell lung cancer: Proposal and application in EGFR tyrosine kinase inhibitor therapy
- (2010) Ho Yun Lee et al. LUNG CANCER
- Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
- (2009) J. D. Wolchok et al. CLINICAL CANCER RESEARCH
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now